CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin inaggressive and hormone-refractory prostate cancer cells
Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolyticherpes simplex virus vector.
Suivez nous